Sema4: Kevin Feeley
Aug 26, 2022
Sema4 has promoted Kevin Feeley to CFO. Feeley will also keep his titles of VP of operations and head of GeneDx, the molecular diagnostics brand that Sema4 acquired from Opko Health in May for $623 million. Feeley previously served as CFO of GeneDx and BioReference Laboratories. Sema4's former CFO, Isaac Ro, left the company earlier this month.